WallStreetZenWallStreetZen

NASDAQ: AXSM
Axsome Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for AXSM

Based on 7 analysts offering 12 month price targets for Axsome Therapeutics Inc.
Min Forecast
$81.00+14.52%
Avg Forecast
$108.43+53.3%
Max Forecast
$180.00+154.49%

Should I buy or sell AXSM stock?

Based on 7 analysts offering ratings for Axsome Therapeutics Inc.
Strong Buy
Strong Buy
4 analysts 57.14%
Buy
1 analysts 14.29%
Hold
2 analysts 28.57%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their AXSM stock forecasts and price targets.

AXSM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Mizuho
Bottom 4%
4
Strong BuyReiterates$100.00+41.38%2023-09-25
Cantor Fitzgerald
Top 6%
95
Strong BuyReiterates$108.00+52.69%2023-08-22
Bank of America
Top 14%
87
HoldUpgrades$81.00+14.52%2023-08-08
HC Wainwright & Co.
Bottom 1%
1
BuyMaintains$180.00+154.49%2023-08-08
Piper Sandler
Top 23%
78
Strong BuyUpgrades$90.00+27.24%2023-08-08Find out why
Guggenheim
Bottom 18%
18
Strong BuyReiterates$110.00+55.52%2023-06-15
Morgan Stanley
Bottom 11%
11
HoldMaintains$90.00+27.24%2023-06-12

1 of 1

Forecast return on equity

Is AXSM forecast to generate an efficient return?
Company
N/A
Industry
0.88%
Market
28.76%

Forecast return on assets

Is AXSM forecast to generate an efficient return on assets?
Company
N/A
Industry
0.06%

AXSM revenue growth forecast

How is AXSM forecast to perform vs Biotechnology companies and vs the US market?
Company
50.9%
Industry
35.88%
Market
8.15%
AXSM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AXSM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AXSM vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
AXSM$70.73$108.43+53.30%Strong Buy
MLTX$53.10$71.00+33.71%Buy
CORT$32.32$30.40-5.94%Buy
FOLD$11.96$16.00+33.78%Buy
RVMD$29.50$38.25+29.66%Strong Buy
View Top Biotech Stocks

Axsome Therapeutics Stock Forecast FAQ

Is Axsome Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: AXSM) stock is to Strong Buy AXSM stock.

Out of 7 analysts, 4 (57.14%) are recommending AXSM as a Strong Buy, 1 (14.29%) are recommending AXSM as a Buy, 2 (28.57%) are recommending AXSM as a Hold, 0 (0%) are recommending AXSM as a Sell, and 0 (0%) are recommending AXSM as a Strong Sell.

If you're new to stock investing, here's how to buy Axsome Therapeutics stock.

What is AXSM's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: AXSM) forecast ROE is N/A, which is considered weak.

What is AXSM's Price Target?

According to 7 Wall Street analysts that have issued a 1 year AXSM price target, the average AXSM price target is $108.43, with the highest AXSM stock price forecast at $180.00 and the lowest AXSM stock price forecast at $81.00.

On average, Wall Street analysts predict that Axsome Therapeutics's share price could reach $108.43 by Sep 25, 2024. The average Axsome Therapeutics stock price prediction forecasts a potential upside of 53.3% from the current AXSM share price of $70.73.

What is AXSM's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: AXSM) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.06%.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.